Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area

This publication has 36 references indexed in Scilit:

• High prevalence of occult hepatitis B in Baltimore injection drug users
  Hepatology, 2004
• Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation
  Liver Transplantation, 2001
• De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor population
  Liver Transplantation, 2001
• Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period
  Bone Marrow Transplantation, 2000
• REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
  Transplantation, 1998
• De novo and apparent de novo hepatitis B virus infection after liver transplantation
  Journal of Hepatology, 1997
• The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient
  Liver Transplantation and Surgery, 1997
• Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus
  Journal of Hepatology, 1995
• Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B
  Digestive Diseases and Sciences, 1995
• The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
  Transplantation, 1995